Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 468901 - 468920 out of 483419 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01AA01) cyclophosphamide | CYCLOPHOSPHAMIDE 100MG/ML INJ,SOLN | 10ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Sandoz,Inc. |
| USA | (L01BC02) fluorouracil | FLUOROURACIL 5% CREAM,TOP | 40GM | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Dr.ReddysLaboratories,Inc. |
| USA | (L01BC02) fluorouracil | FLUOROURACIL 5% CREAM,TOP | 40GM | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Dr.ReddysLaboratories,Inc. |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG ORAL GRANULES | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (L01EX27) capivasertib | TRUQAP 160MG TAB | 4x16 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EX27) capivasertib | TRUQAP 200MG TAB | 4x16 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01FC01) daratumumab | DARZALEX 400MG/20ML INJ SOLN | 1X20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FC01) daratumumab | DARZALEX 400MG/20ML INJ SOLN | 1X20ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.25MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.25MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.35MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.35MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.5MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.5MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.75MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 0.75MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
| USA | (L01XK04) talazoparib | TALZENNA 1MG CAP,ORAL | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | Pfizer,Inc. |
Pages
